Co production of 2,6-[18F] DifluoroDOPA during electrophilic synthesis of 6-[18F]Fluoro-L-DOPA

Nuclear Medicine and Biology

Volumn 23, Issue 1, 1996, Pages 101-103

  Hatano, K ^a   Ishiwata, K ^a   Yanagisawa, T ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2,6 DIFLUORODOPA F 18; 6 FLUORODOPA F 18; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG IMPURITY; DRUG SYNTHESIS; ISOTOPE LABELING; MOUSE;

EID: 0030062598     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(96)90004-9     Document Type: Article

References (8)

1. 18F]6-fluotodopa with fluorine-18 acetyl hypofluorite J. Nucl. Med. 27 1986 1462 1466
2. B.-H. Chen J.-Y. Nie M.J. Sloan V.W. Pike K.L. Kirk Fluorinated cathecholamino acids as potential prodrugs The 14th International Symposium on Fluorine Chemistry Yokohama, Japan 1994
3. G.T. Chen M. King F. Gusovsky C.R. Creveling J.W. Daly B.-H. Cheng J.-Y. Nie K.L. Kirk Synthesis of 2,5- and 2,6-difluoronorepinephrine, 2,5-difluoroepinephrine, and 2,6-difluorophenylephrine: Effect of disubstitution with fluorine on adrenergic activity J. Med. Chem. 36 1993 3947 3955
4. 18F]fluoro- l -DOPA J. Nucl. Med. 25 1984 1228 1233
5. M. Ihara Y. Tsuchiya Y. Sawasaki A. Hisaka H. Takehara K. Tomimoto M. Yano A new potential prodrug to improve the duration of l -dopa: l -3-(3-hydroxy-4-pivaloyloxyphenyl)alanine J. Pharm. Sci. 78 1989 525 529
6. 18F]fluoro- l -DOPA: Use of 4- O -pivaloyl- l -DOPA as a suitable precursor for routine production Appl. Radiat. Isot. 44 1993 755 759
7. 18F-labeled dopa prodrug as a PET tracer for studying brain dopamine metabolism.
8. 18F]fluoro- l -DOPA and its metabolism in vivo —a critical review Nucl. Med. Biol. 19 1992 149 158